Show simple item record

dc.contributor.authorBeran, RG
dc.date.accessioned2021-10-17T04:37:05Z
dc.date.available2021-10-17T04:37:05Z
dc.date.issued2016
dc.identifier.issn1356-5524
dc.identifier.doi10.1136/ebmed-2015-110291
dc.identifier.urihttp://hdl.handle.net/10072/409119
dc.description.abstractTension-type headache (TTH) is the most common form of primary headache. Aetiology of TTH is far from categorical, as is reflected by the wealth of synonymous identifiers, such as tension headache, muscle contraction headache, psychomyelogenic headache or psychogenic headache, to name but a few. The condition can however be divided into infrequent, more frequent and chronic forms, based on the number of headaches and headache days per month. Infrequent episodic TTH has a prevalence rate of approximately 40% while almost one-third of 40-year-olds have frequent episodic TTH, having a profound negative impact on societal productivity. Most of those who experience episodic TTH self-medicate with over-the-counter (OTC) remedies of which ibuprofen is but one available treatment.
dc.languageeng
dc.publisherBMJ Publishing Group
dc.relation.ispartofpagefrom62
dc.relation.ispartofpageto62
dc.relation.ispartofissue2
dc.relation.ispartofjournalEvidence-Based Medicine
dc.relation.ispartofvolume21
dc.subject.fieldofresearchClinical sciences
dc.subject.fieldofresearchcode3202
dc.titleIbuprofen for the treatment of TTH
dc.typeJournal article
dc.type.descriptionC3 - Articles (Letter/ Note)
dcterms.bibliographicCitationBeran, RG, Ibuprofen for the treatment of TTH, Evidence-Based Medicine, 2016, 21 (2), pp. 62-62
dc.date.updated2021-10-17T04:35:17Z
gro.hasfulltextNo Full Text
gro.griffith.authorBeran, Roy G.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record